<qa>  What is the p-value for the ASLAN001-containing treatment arm?In the absence of any safety or tolerability concerns, continuation to the Phase 2B part of the study will be primarily based on the statistical comparison of the percentage change in tumor size from baseline to Week 12 and a one-sided p-value 0.1 in favor of the ASLAN001-containing treatment arm would be supportive of continuation to Phase 2B. 